U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758270) titled 'Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.' on A... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757178) titled 'Lived Experience Narratives in Dementia' on July 28. Brief Summary: The Lived Experience N... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758803) titled 'A Randomized Controlled Trial Comparing the Effects of Different Anesthetic Sedatives on PO... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758582) titled 'Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Aut... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Functional magnetic resonance imaging study of basal ganglia circuits in Parkinson's di... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The impact of osteonecrosis of the femoral head classification on the efficacy of combi... Read More
China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Cohort Study of Osimertinib Combined with Pemetrexed and Carboplatin as First-Line Ther... Read More